Skip to content
The Nexus
DossierENTITY

UTHR

Coverage of UTHR in the Nexus archive.

Earliest in view: Aug 5 · 10:40 UTCMost recent: Aug 5 · 10:40 UTC
Co-mentioned in this coverage
United Therapeuticsorganization1Zacks Investment Researchorganization1Automated Insightsorganization1
Recent coverage
  • BUSINESSAug 5 · 10:40 UTCWTOP DC
    United Therapeutics: Q2 Earnings Snapshot

    United Therapeutics Corp. reported second-quarter net income of $333 million with $7.27 per share, exceeding Wall Street's $6.82 per share estimate. However, revenue of $783.3 million fell short of the $803.5 million forecast.

UTHR · Dossier · The Nexus